Integrating daclatasvir into hepatitis c therapy.
Publication
, Journal Article
Oloruntoba, O; Muir, AJ
Published in: Clin Liver Dis (Hoboken)
January 2016
Duke Scholars
Published In
Clin Liver Dis (Hoboken)
DOI
ISSN
2046-2484
Publication Date
January 2016
Volume
7
Issue
1
Start / End Page
1 / 4
Location
United States
Citation
APA
Chicago
ICMJE
MLA
NLM
Oloruntoba, O., & Muir, A. J. (2016). Integrating daclatasvir into hepatitis c therapy. Clin Liver Dis (Hoboken), 7(1), 1–4. https://doi.org/10.1002/cld.524
Oloruntoba, Omobonike, and Andrew J. Muir. “Integrating daclatasvir into hepatitis c therapy.” Clin Liver Dis (Hoboken) 7, no. 1 (January 2016): 1–4. https://doi.org/10.1002/cld.524.
Oloruntoba O, Muir AJ. Integrating daclatasvir into hepatitis c therapy. Clin Liver Dis (Hoboken). 2016 Jan;7(1):1–4.
Oloruntoba, Omobonike, and Andrew J. Muir. “Integrating daclatasvir into hepatitis c therapy.” Clin Liver Dis (Hoboken), vol. 7, no. 1, Jan. 2016, pp. 1–4. Pubmed, doi:10.1002/cld.524.
Oloruntoba O, Muir AJ. Integrating daclatasvir into hepatitis c therapy. Clin Liver Dis (Hoboken). 2016 Jan;7(1):1–4.
Published In
Clin Liver Dis (Hoboken)
DOI
ISSN
2046-2484
Publication Date
January 2016
Volume
7
Issue
1
Start / End Page
1 / 4
Location
United States